These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case. Kogej T, Blomberg N, Greasley PJ, Mundt S, Vainio MJ, Schamberger J, Schmidt G, Hüser J. Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858 [Abstract] [Full Text] [Related]
16. Automated recycling of chemistry for virtual screening and library design. Vainio MJ, Kogej T, Raubacher F. J Chem Inf Model; 2012 Jul 23; 52(7):1777-86. PubMed ID: 22657574 [Abstract] [Full Text] [Related]
17. Charting, navigating, and populating natural product chemical space for drug discovery. Lachance H, Wetzel S, Kumar K, Waldmann H. J Med Chem; 2012 Jul 12; 55(13):5989-6001. PubMed ID: 22537178 [Abstract] [Full Text] [Related]
18. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity. Sukuru SC, Jenkins JL, Beckwith RE, Scheiber J, Bender A, Mikhailov D, Davies JW, Glick M. J Biomol Screen; 2009 Jul 12; 14(6):690-9. PubMed ID: 19531667 [Abstract] [Full Text] [Related]
19. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates. Liu Y, Beresini MH, Johnson A, Mintzer R, Shah K, Clark K, Schmidt S, Lewis C, Liimatta M, Elliott LO, Gustafson A, Heise CE. J Biomol Screen; 2012 Feb 12; 17(2):225-36. PubMed ID: 21940710 [Abstract] [Full Text] [Related]
20. Comparison of compound administration methods in biochemical assays: effects on apparent compound potency using either assay-ready compound plates or pin tool-delivered compounds. Smith T, Ho PI, Yue K, Itkin Z, MacDougall D, Paolucci M, Hill A, Auld DS. J Biomol Screen; 2013 Jan 12; 18(1):14-25. PubMed ID: 22904199 [Abstract] [Full Text] [Related] Page: [Next] [New Search]